Literature DB >> 18477145

Impact of smoking on pemphigus.

Mahin Valikhani1, Suzan Kavusi, Cheyda Chams-Davatchi, Zahra Hallaji, Nafiseh Esmaili, Narges Ghandi, Farzaneh Farahani, Vahide Lajevardi.   

Abstract

BACKGROUND: A positive history of smoking is less common in patients with pemphigus than in healthy subjects. The aim of this case-control study was to compare the remission rate and clinical locations involved in smokers and nonsmokers with pemphigus vulgaris.
METHODS: Seventy patients with pemphigus vulgaris, treated with a uniform protocol, were enrolled. The sites of involvement, average time needed for disease control, and number of relapses were compared in smokers and nonsmokers. At the end of the first and second years of treatment, the rate of remission was compared in the two groups.
RESULTS: Ten of the patients were current cigarette smokers, but the other 60 (85.7%) had no history of smoking. There was no difference in the rate of cutaneous or mucosal involvement between smokers and nonsmokers. The predominant subtype was the mucocutaneous type in both groups. Smokers with pemphigus vulgaris achieved partial remission more frequently than nonsmokers at the end of the first year of treatment. The number of patients in remission at the end of the second year of therapy was significantly higher for smokers with pemphigus than for nonsmokers. The main reason for disease activity in both groups was recurrence.
CONCLUSIONS: Cigarette smoking may not affect the rate of cutaneous or mucosal involvement in pemphigus; however, the data indicate that remission may be achieved sooner in pemphigus patients who smoke.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477145     DOI: 10.1111/j.1365-4632.2008.03645.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Cigarette smoking associates inversely with a cluster of two autoimmune diseases: ulcerative colitis and pemphigus.

Authors:  Khalaf Kridin; Hadas Zamir; Arnon D Cohen
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

Review 2.  Pemphigus autoimmunity: hypotheses and realities.

Authors:  Sergei A Grando
Journal:  Autoimmunity       Date:  2011-09-23       Impact factor: 2.815

3.  Prediction of survival for patients with pemphigus vulgaris and pemphigus foliaceus: a retrospective cohort study.

Authors:  Adrian Baican; Roxana Chiorean; Daniel Corneliu Leucuta; Corina Baican; Sorina Danescu; Dorina Ciuce; Cassian Sitaru
Journal:  Orphanet J Rare Dis       Date:  2015-04-22       Impact factor: 4.123

Review 4.  The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the "Super Compensation Hypothesis".

Authors:  Animesh A Sinha; Thomas Sajda
Journal:  Front Med (Lausanne)       Date:  2018-08-14

5.  Association between vitiligo and smoking: A nationwide population-based study in Korea.

Authors:  Ji Hyun Lee; Yong Gyu Park; Young Bok Lee; Soo Young Lee; Dong Soo Yu; Kyung Do Han
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

Review 6.  Autoimmune Pemphigus: Latest Advances and Emerging Therapies.

Authors:  Yen Loo Lim; Gerome Bohelay; Sho Hanakawa; Philippe Musette; Baptiste Janela
Journal:  Front Mol Biosci       Date:  2022-02-04

Review 7.  Mitochondrial Autoantibodies and the Role of Apoptosis in Pemphigus Vulgaris.

Authors:  Dana M Hutchison; Anna-Marie Hosking; Ellen M Hong; Sergei A Grando
Journal:  Antibodies (Basel)       Date:  2022-08-25

8.  Smoking and nicotine exposure delay development of collagen-induced arthritis in mice.

Authors:  Sofia S Lindblad; Piotr Mydel; Ing-Marie Jonsson; Robert M Senior; Andrej Tarkowski; Maria Bokarewa
Journal:  Arthritis Res Ther       Date:  2009-06-11       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.